Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Operating Cash Flow
Cash generated by the company's core business operations during the period.
Operating Cash Flow history
Currency unavailable · from the cash flow
No Operating Cash Flow data reported for this period type.
Operating Cash Flow vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $778.92M USD | -7.8% | +32.7% | 68.5% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 225.86M SEK | -31.6% | +7.8% | 16982.6% |
| LTM Mar 2026 | $18.83M USD | -36.0% | — | 5.2% | |
| LTM Mar 2026 | $4.32M USD | +163.3% | -54.4% | 3.7% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -19.7% | +7.8% | 36.8% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.